I70.29
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Peripheral arterial vascular disease (stage III & IV) with ulceration/s at the lower extremity/extremities, age < 17 years, informed consent on the study
Exclusion criteria
Exclusion criteria: Inability of the patient to give informed consent, terminal disease with life expectancy < 12 months, malign tumor disease, condition after organ transplantation, participation in a pharmacological study, pregnancy, implanted insulin pump, implanted cardiac pacemaker, dementia or cognitive dysfunction
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Proof of a 10 % improved microcirculation in the lower extremities or wound healing (visual appearance, wound size, wound bed), if applicable complete wound closure | — |
Secondary
| Measure | Time frame |
|---|---|
| Improvement of the quality of life, reduction of pain, improvement of sleep quality | — |
Countries
Germany
Contacts
Klinik und Poliklinik für GefäßmedizinUniversitätsklinikum Hamburg-Eppendorf